Literature DB >> 12011429

The c-Myc target gene PRDX3 is required for mitochondrial homeostasis and neoplastic transformation.

Diane R Wonsey1, Karen I Zeller, Chi V Dang.   

Abstract

Deregulated expression of the c-Myc transcription factor is found in a wide variety of human tumors. Because of this significant role in oncogenesis, considerable effort has been devoted to elucidating the molecular program initiated by deregulated c-myc expression. The primary transforming activity of Myc is thought to arise through transcriptional regulation of numerous target genes. Thus far, Myc target genes involved in mitochondrial function have not been characterized in depth. Here, we describe a nuclear c-Myc target gene, PRDX3, which encodes a mitochondrial protein of the peroxiredoxin gene family. Expression of PRDX3 is induced by the mycER system and is reduced in c-myc(-/-) cells. Chromatin immunoprecipitation analysis spanning the entire PRDX3 genomic sequence reveals that Myc binds preferentially to a 930-bp region surrounding exon 1. We show that PRDX3 is required for Myc-mediated proliferation, transformation, and apoptosis after glucose withdrawal. Results using mitochondria-specific fluorescent probes demonstrate that PRDX3 is essential for maintaining mitochondrial mass and membrane potential in transformed rat and human cells. These data provide evidence that PRDX3 is a c-Myc target gene that is required to maintain normal mitochondrial function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12011429      PMCID: PMC124457          DOI: 10.1073/pnas.102523299

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Identification of putative c-Myc-responsive genes: characterization of rcl, a novel growth-related gene.

Authors:  B C Lewis; H Shim; Q Li; C S Wu; L A Lee; A Maity; C V Dang
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination.

Authors:  M K Mateyak; A J Obaya; S Adachi; J M Sedivy
Journal:  Cell Growth Differ       Date:  1997-10

3.  A unique glucose-dependent apoptotic pathway induced by c-Myc.

Authors:  H Shim; Y S Chun; B C Lewis; C V Dang
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

4.  c-Myc induces apoptosis and cell cycle progression by separable, yet overlapping, pathways.

Authors:  G Packham; C W Porter; J L Cleveland
Journal:  Oncogene       Date:  1996-08-01       Impact factor: 9.867

5.  Glucose deprivation-induced cytotoxicity and alterations in mitogen-activated protein kinase activation are mediated by oxidative stress in multidrug-resistant human breast carcinoma cells.

Authors:  Y J Lee; S S Galoforo; C M Berns; J C Chen; B H Davis; J E Sim; P M Corry; D R Spitz
Journal:  J Biol Chem       Date:  1998-02-27       Impact factor: 5.157

6.  Thioredoxin peroxidase is a novel inhibitor of apoptosis with a mechanism distinct from that of Bcl-2.

Authors:  P Zhang; B Liu; S W Kang; M S Seo; S G Rhee; L M Obeid
Journal:  J Biol Chem       Date:  1997-12-05       Impact factor: 5.157

7.  Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo.

Authors:  C Grandori; J Mac; F Siëbelt; D E Ayer; R N Eisenman
Journal:  EMBO J       Date:  1996-08-15       Impact factor: 11.598

8.  Mammalian antioxidant protein complements alkylhydroperoxide reductase (ahpC) mutation in Escherichia coli.

Authors:  K Tsuji; N G Copeland; N A Jenkins; M Obinata
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

9.  A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins.

Authors:  T D Littlewood; D C Hancock; P S Danielian; M G Parker; G I Evan
Journal:  Nucleic Acids Res       Date:  1995-05-25       Impact factor: 16.971

10.  Glucose deprivation-induced cytotoxicity in drug resistant human breast carcinoma MCF-7/ADR cells: role of c-myc and bcl-2 in apoptotic cell death.

Authors:  Y J Lee; S S Galoforo; C M Berns; W P Tong; H R Kim; P M Corry
Journal:  J Cell Sci       Date:  1997-03       Impact factor: 5.285

View more
  59 in total

Review 1.  The functional role of peroxiredoxin 3 in reactive oxygen species, apoptosis, and chemoresistance of cancer cells.

Authors:  Lianqin Li; Ai-Qun Yu
Journal:  J Cancer Res Clin Oncol       Date:  2015-01-21       Impact factor: 4.553

2.  Phosphorylation and cleavage of presenilin-associated rhomboid-like protein (PARL) promotes changes in mitochondrial morphology.

Authors:  Danny V Jeyaraju; Liqun Xu; Marie-Claude Letellier; Sirisha Bandaru; Rodolfo Zunino; Eric A Berg; Heidi M McBride; Luca Pellegrini
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-20       Impact factor: 11.205

3.  Construction of eukaryotic expression plasmid of human PRX3 and its expression in HEK-293FT cells.

Authors:  Yan Feng; Zhao Liu; Huiqing Cao; Xianmin Meng; Zhiling Qu; Mi Xiong; Zhongduan Deng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

Review 4.  Mitochondrial thiols in the regulation of cell death pathways.

Authors:  Fei Yin; Harsh Sancheti; Enrique Cadenas
Journal:  Antioxid Redox Signal       Date:  2012-06-11       Impact factor: 8.401

5.  Conjugated linoleic acid isomers modulate protein expression profile in rat hepatocytes.

Authors:  E Rossi; L Della Casa; S Piana; A Iannone
Journal:  Genes Nutr       Date:  2012-05-05       Impact factor: 5.523

Review 6.  The sulfiredoxin-peroxiredoxin (Srx-Prx) axis in cell signal transduction and cancer development.

Authors:  Murli Mishra; Hong Jiang; Lisha Wu; Hedy A Chawsheen; Qiou Wei
Journal:  Cancer Lett       Date:  2015-07-10       Impact factor: 8.679

7.  Essential role of JunD in cell proliferation is mediated via MYC signaling in prostate cancer cells.

Authors:  Bethtrice Elliott; Ana Cecilia Millena; Lilya Matyunina; Mengnan Zhang; Jin Zou; Guangdi Wang; Qiang Zhang; Nathan Bowen; Vanessa Eaton; Gabrielle Webb; Shadyra Thompson; John McDonald; Shafiq Khan
Journal:  Cancer Lett       Date:  2019-02-11       Impact factor: 8.679

Review 8.  MYC, Metabolism, and Cancer.

Authors:  Zachary E Stine; Zandra E Walton; Brian J Altman; Annie L Hsieh; Chi V Dang
Journal:  Cancer Discov       Date:  2015-09-17       Impact factor: 39.397

9.  Overexpression of peroxiredoxin-3 and -5 is a potential biomarker for prognosis in endometrial cancer.

Authors:  Jung Mi Byun; Su Sun Kim; Ki Tae Kim; Mi Seon Kang; Dae Hoon Jeong; Dae Sim Lee; Eun Jung Jung; Young Nam Kim; Jin Han; In Sung Song; Kyoun Bok Lee; Moon Su Sung
Journal:  Oncol Lett       Date:  2018-01-31       Impact factor: 2.967

10.  Specific expression profile and prognostic significance of peroxiredoxins in grade II-IV astrocytic brain tumors.

Authors:  Sally Järvelä; Immo Rantala; Alejandra Rodriguez; Heini Kallio; Seppo Parkkila; Vuokko L Kinnula; Ylermi Soini; Hannu Haapasalo
Journal:  BMC Cancer       Date:  2010-03-22       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.